Proceeds to Fund Advancement of Programs Addressing Acute Lung Injury Due to COVID-19 and Severe Birth Asphyxia (HIE) Norfolk, VA, April 21, 2020 — ReAlta Life […]

Norfolk, VA, April 9, 2020 — ReAlta Life Sciences, Inc., a biotech company dedicated to harnessing the power of the immune system through its PIC1 technology […]

Norfolk, VA, March 10, 2020 — ReAlta Life Sciences, Inc., a biotechnology company dedicated to harnessing the power of the immune system to address life-threatening medical […]

PIC1 positioned as a novel pharmacological intervention to improve survival and cognitive outcomes for newborns affected by devastating disease Norfolk, VA, February 6, 2020 — ReAlta […]

THE VIRGINIAN-PILOT | DEC 29, 2019 https://www.pilotonline.com/news/health/vp-nw-fzx19-realta-life-sciences-20191229-ufzi7vhgu5f3nppfatihjcgq3a-story.html

Norfolk, VA, November 6, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming Complement-based Drug Development Summit being held November 13-15, 2019 in Boston, […]

Norfolk, VA, October 30, 2019 — ReAlta Life Sciences, Inc. announced today that it will participate in the upcoming BIOEurope® 2019 – 25th Annual International Partnering Conference being held November 11-13, […]

NORFOLK, VA– Ulrich Thienel MD, PhD, has been appointed by the ReAlta Life Sciences Board of Directors as Chief Executive Officer, effective September 1, 2019.  In […]

CRCF invests in priority research and commercialization activities through the private sector, academia, and nonprofit research institutes RICHMOND—Governor Ralph Northam today announced $2.51 million in funding […]

ReAlta Life Sciences, Inc. has been awarded a $1.5 million grant by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health […]